Scand J Rheumatol 2019;48:519. doi: 10.1080/03009742.2019.1655241.
We, the Editor and Publishers of the Scandinavian Journal of Rheumatology, have retracted the following article:
H Sun, Y Wang, H Yao, L Wang, S Wu, Y Si, Y Meng, J Xu, Q Wang, X Sun & Z Li (2019). The clinical significance of serum sCD25 as a sensitive disease activity marker for rheumatoid arthritis. Scandinavian Journal of Rheumatology 48(5). DOI: 10.1080/03009742.2019.1574890.
The above article has been retracted as a result of an article with a significant overlap in content having been published in the Journal of Peking University (Health Sciences) as
Xu Jia-jia, Wang Yan, Sun He, Jia Ru-lin, Zhang Xue-wu, Meng Yang, Ren Li-li, Sun Xiao-lin (2018). Clinical significance of detection of soluble interleukin 2 receptor alpha chain in the assessment of rheumatoid arthritis disease activity. Journal of Peking University (Health Sciences) 50(6):975–80. DOI: 10.19723/j.issn.1671-167X.2018.06.006. The authors have taken full responsibility for this error and have agreed to the retraction.
We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ’Retracted’.
Authors’ comments to the retraction
Scand J Rheumatol 2019;48:519. doi: 10.1080/03009742.2019.1653494.
Y Wang, Department of Rheumatology and Immunology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
X Sun, Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing, China.
We, the co-first author and corresponding author of the retracted paper ‘The clinical significance of serum sCD25 as a sensitive disease activity marker for rheumatoid arthritis. Scandinavian Journal of Rheumatology, published online, DOI: 10.1080/03009742.2019.1574890’, apologize to the journal and readers for our error.
As the leaders of the research team of this study, in late June 2019, when the paper was published early online, we noticed that some of the co-authors had published another research paper in Chinese language in a local journal, ‘Journal of Peking University (Health Sciences) 50(6):975–80’, without fully informing us that there was a significant overlap in content of these two papers. The authors of the latter paper did this because they thought that publishing a paper in Chinese language would not contradict our submission to Scandinavian Journal of Rheumatology in English. Clearly, this is a misunderstanding of the academic rules. We immediately reported this issue to the Editor and proposed the retraction of our paper from SJR before its publication in print. Here, we apologize to the journal and readers for our failure of supervision and management in the publication of data by our team, and also apologize to the co-authors who were not involved in publishing the Chinese paper. We take full responsibility for this error.
Yan Wang [email protected]; Xiaolin Sun [email protected]